[{"id":"77153b61-c254-4d36-83e7-366b559ddf6c","acronym":"Capella","url":"https://clinicaltrials.gov/study/NCT05493800","created_at":"2022-08-09T17:04:52.927Z","updated_at":"2024-07-02T16:35:00.581Z","phase":"Phase 2","brief_title":"Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT","source_id_and_acronym":"NCT05493800 - Capella","lead_sponsor":"MitoImmune Therapeutics","biomarkers":" CD34","pipe":"","alterations":" ","tags":["CD34"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MIT-001"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 02/01/2022","start_date":" 02/01/2022","primary_txt":" Primary completion: 06/30/2024","primary_completion_date":" 06/30/2024","study_txt":" Completion: 12/30/2024","study_completion_date":" 12/30/2024","last_update_posted":"2024-05-29"},{"id":"95201ef8-2fab-45a7-9703-ae99f68e157d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04388475","created_at":"2021-07-05T17:30:04.951Z","updated_at":"2024-07-02T16:35:11.963Z","phase":"Phase 2","brief_title":"Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma","source_id_and_acronym":"NCT04388475","lead_sponsor":"Oblato, Inc.","biomarkers":" MGMT","pipe":"","alterations":" ","tags":["MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide • disufenton sodium (OKN-007)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 57","initiation":"Initiation: 06/12/2020","start_date":" 06/12/2020","primary_txt":" Primary completion: 06/30/2024","primary_completion_date":" 06/30/2024","study_txt":" Completion: 01/31/2025","study_completion_date":" 01/31/2025","last_update_posted":"2024-04-02"},{"id":"db595308-3a83-436c-be31-776d9cd4922c","acronym":"","url":"https://clinicaltrials.gov/study/NCT03702985","created_at":"2021-01-18T18:08:47.432Z","updated_at":"2024-07-02T16:37:03.552Z","phase":"Phase 2","brief_title":"Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer","source_id_and_acronym":"NCT03702985","lead_sponsor":"Fudan University","biomarkers":" UGT1A1","pipe":" | ","alterations":" UGT1A1*28 • UGT1A1*1*1","tags":["UGT1A1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e UGT1A1*28 • UGT1A1*1*1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e capecitabine • irinotecan • amifostine"],"overall_status":"Unknown status","enrollment":" Enrollment 160","initiation":"Initiation: 05/28/2018","start_date":" 05/28/2018","primary_txt":" Primary completion: 11/01/2019","primary_completion_date":" 11/01/2019","study_txt":" Completion: 03/01/2020","study_completion_date":" 03/01/2020","last_update_posted":"2019-01-23"}]